| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers I > Headlines for InterMune Inc. > News item |
OrbiMed Advisors slashes stake to 6.54% in InterMune
By E. Janene Geiss
Philadelphia, Dec. 19 - OrbiMed Advisors LLC decreased its investment to 6.54% in InterMune Inc. as of Dec. 5, according to an SC 13G filing with the Securities and Exchange Commission.
That represents a passive stake of 2,570,744 shares.
Those holdings are down from the passive stake of 11.56%, or 4,505,400 shares, that the company reported owning Dec. 31, 2007.
The company first reported holdings of 5.43%, or 1,847,800 shares, on Jan. 3, 2007.
Brisbane, Calif.-based InterMune is a biotechnology company focused on treatments for pulmonary, infectious and hepatic diseases.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.